Abstract:Background: Hypophosphatasia (HPP) is an inherited metabolic bone disease characterized by reduced mineralization due to mutations in the tissue non-specific alkaline phosphatase (ALPL) gene. HPP is clinically variable with extensive allelic heterogeneity in the ALPL gene. We report the findings of in vitro functional studies following site-directed mutagenesis in bi-allelic mutations causing extreme clinical phenotypes; severe perinatal and asymptomatic HPP. Aims: Elucidate genotype-phenotype correlation using in vitro functional studies and 3 dimensional (3D) ALP modelling. Methods: Clinical, biochemical and radiological features were recorded in two children with extreme HPP phenotypes: Subject 1 (S1): Perinatal HPP with compound heterozygous mutations (c.110T>C; c.532T>C); Subject 2 (S2): asymptomatic with homozygous missense mutation (c.715G>T). Plasmids created for mutants 1 c.110T>C (L37P), 2 c.532T>C (Y178H) and 3 c.715G>T (D239Y) using in vitro mutagenesis were transfected into human osteosarcoma (U2OS) cells and compared to wildtype (WT) and mock cDNA. ALP activity was measured using enzyme kinetics with p-nitrophenylphosphate. Mineral deposition was evaluated photometrically with Alizarin Red S staining after culture with mineralization medium. Western blot analysis was performed to identify the mature type protein expression (80 kDa). Mutations were located on a 3D ALP model. Co-transfection was performed to identify dominant negative effect of the mutants. Results: Phenotype: S1, had typical perinatal HPP phenotype at birth; extremely under-mineralized bones and pulmonary hypoplasia. S2, diagnosed incidentally by laboratory tests at 4 years, had normal growth, development, dentition and radiology. All S2's siblings (3 homozygous, 1 heterozygous) were asymptomatic. All subjects had typical biochemical features of HPP (low ALP, high serum pyridoxal-5'-phosphate), except the heterozygous sibling (normal ALP). Functional assay: Mutants 1 and 2 demonstrated negligible ALP activity and mineralization was 7.9% and 9.3% of WT, respectively. Mutant 3 demonstrated about 50% ALP activity and 15.5% mineralization of WT. On Western blot analysis, mutants 1 and 2 were detected as faint bands indicating reduced expression and mutant 3 was expressed as mature form protein with 50% of WT expression. Mutant 1 was located near the Glycosylphosphatidylinositol anchor, 2 at the core structure of the ALP protein and 3 at the periphery of the protein structure. Co-transfection did not reveal a dominant negative effect in any of the mutants. Conclusion: Our findings expand the current knowledge of functional effect of individual mutations and the importance of their location in the ALP structure.

One Patient with Perinatal Hypophosphatasia Due to Mutations in the Tissue-Nonspecific Alkaline Phosphatase Gene

Lethal Perinatal Hypophosphatasia Caused by a Novel Compound Heterozygous Mutation: a Case Report

Case Report: Variations in the ALPL Gene in Chinese Patients With Hypophosphatasia

Six ALPL gene variants in five children with hypophosphatasia

Tissue non-specific alkaline phosphatase activity and mineralization capacity of bi-allelic mutations from severe perinatal and asymptomatic hypophosphatasia phenotypes: Results from an in vitro mutagenesis model

A case report of odonto-hypophosphatasia with a novel variant in the ALPL gene

[Pseudohypoparathyroidism and GNAS Gene Defects: Clinical Evaluation and Molecular Analysis in 20 Children].

Systemic effects of hypophosphatasia characterization of two novel variants in the ALPL gene

Impact of pediatric hypophosphatasia on behavioral health and quality of life

Characterization of Genetic Variants of Uncertain Significance for the ALPL Gene in Patients With Adult Hypophosphatasia

The structural pathology for hypophosphatasia caused by malfunctional tissue non-specific alkaline phosphatase

A Novel Case of Concomitant PHEX and ALPL Mutation In a Family With Rickets

Neuromuscular features of hypophosphatasia

A Novel Missense Mutation in the Alpl Gene Causes Dysfunction of the Protein

Identification of a Novel Mutation in Pseudohypoparathyroidism Type Ia in a Chinese Family

Differential diagnosis of perinatal hypophosphatasia: radiologic perspectives

Hypophosphatasia: Vitamin B6 status of affected children and adults

New insights into the landscape of ALPL gene variants in patients with hypophosphatasia from the Global HPP Registry

Tissue nonspecific alkaline phosphatase deficiency impairs Purkinje cell development and survival in a mouse model of infantile hypophosphatasia

Functional Evaluation of Mutations in the Tissue-Nonspecific Alkaline Phosphatase Gene.

A de novo mosaic mutation of PHEX in a boy with hypophosphatemic rickets